Cell Free RNA Diagnostics Market Research 2025-2035: Trends Shaping the Market and Growth Projections by Product Type, Sample, Application, Technology, and Geography with Profiles of the M...
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
Type, Sample, Application, Technology, and Geography" report has been added to ResearchAndMarkets.com's offering. Key players in the Cell Free RNA Diagnostics market include Agilent Technologies, Inc.; AMS Biotechnology (Europe) Ltd.; Bio-Rad Laboratories, Inc.; BioVision, Inc.; Canopy Biosciences, LLC; F. Hoffmann-La Roche Ltd.; Geneaid Biotech Ltd.; Illumina, Inc.; QIAGEN N.V.; Lexogen GmbH; LGC Biosearch Technologies; and Merck KGaA. Cell-free RNA diagnostics is a rapidly advancing field that holds great promise for early disease detection, monitoring, and personalized medicine. Several factors, such as the growing demand for non-invasive diagnostic treatments, early disease detection, and the increasing need for personalized and targeted therapies, are driving the adoption of cell-free RNA (cfRNA) as a promising diagnostic tool. cfRNA offers significant advantages over traditional diagnostic methods, such as biopsies and imaging, by enabling non-invasive testing. One of the
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies (NYSE:A) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $165.00 price target on the stock.MarketBeat
- Agilent Technologies (A): Valuation Check After Earnings Beat, Analyst Upgrades, and Initial Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies (NYSE:A) had its "hold (c+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- 2031??45?1,700????????CAGR22.3%?????????????????????:???????????????????? [CNET News]CNET News
A
Earnings
- 11/24/25 - In-Line
A
Sec Filings
- 12/3/25 - Form 4
- 12/1/25 - Form 4
- 12/1/25 - Form 4
- A's page on the SEC website